News Conference News TCT 2025 More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain Yael L. Maxwell October 26, 2025
News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Daily News People With Tricuspid Valve Disease Want More Information, Sooner Yael L. Maxwell July 17, 2025
News Conference News NY Valves 2025 Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL Yael L. Maxwell July 01, 2025
News Daily News ‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use Yael L. Maxwell June 18, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News THT 2025 Questioning the KCCQ: Experts Debate Its Validity as QoL Metric Todd Neale February 19, 2025
News Conference News PCR London Valves 2024 Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE Michael O'Riordan December 03, 2024
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024
News Daily News Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE Caitlin E. Cox September 12, 2024
News Conference News ESC 2024 Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER Todd Neale August 31, 2024
News Conference News NY Valves 2024 T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies Todd Neale June 07, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation Michael O'Riordan February 13, 2024